The team of Professor Ma Jun of the Cancer Prevention Center of Sun Yat-sen University, together with 7 domestic medical centers including the Cancer Hospital of Fudan University and Zhejiang Cancer Hospital, through prospective multi-center randomized controlled clinical trials, found that the clinical The standard treatment plan, that is, concurrent radiotherapy and chemotherapy plus three courses of "cisplatin + fluorouracil" (PF) adjuvant chemotherapy, adjuvant chemotherapy failed to bring further survival benefits. This result was published as a research article (ResearchArticle) in the sub-journal of Lancet magazine, TheLancet Oncology (2012,109 (4): 1127–32).
Sichuan Soper Science & Technilogy Co., Ltd , https://www.Soper.com.cn